Nonopioid drugs for pain management; require health plans and Medicaid to cover and not make use of more restrictive than for opioid drugs.
Requires managed care providers and the medical assistance program shall cover prescription drugs approved by the federal food and drug administration for chronic weight management in adults with obesity with at least one weight-related condition.
A bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan.
A bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan.
Relates to program eligibility for plans comparable to Medicare part D; provides for analysis of health plans by the department of health to determine whether such health plans meet or exceed the Medicare part D standard; requires the department of health, in consultation with the department of financial services, to notify prescription drug insurers of the provisions of this act.
Relates to program eligibility for plans comparable to Medicare part D; provides for analysis of health plans by the department of health to determine whether such health plans meet or exceed the Medicare part D standard; requires the department of health, in consultation with the department of financial services, to notify prescription drug insurers of the provisions of this act.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.